Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 28,215 shares at $37.28 ($1.0M) on 2021-04-01, disclosed to the SEC on 2021-04-05.
Open-market sale of $1.0M PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.28 | 3,405 | $127K | 12.3% |
| 2 | $37.28 | 3,405 | $127K | 12.3% |
| 3 | $38.14 | 1,742 | $66K | 6.4% |
| 4 | $38.14 | 1,742 | $66K | 6.4% |
| 5 | $35.66 | 4,252 | $152K | 14.7% |
| 6 | $35.66 | 4,252 |
| $152K |
| 14.7% |
| 7 | $36.37 | 4,316 | $157K | 15.2% |
| 8 | $36.37 | 4,316 | $157K | 15.2% |
| 9 | $37.11 | 785 | $29K | 2.8% |
| Total | $36.61 avg | 28,215 | $1.0M | 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |